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Proteinuria screening for children.
Background. In Japan, urine screenings are performed annu-
ally at school for proteinuria and hematuria, but the effective-
ness of this practice has not been clarified.
Methods. Urine screening at school was performed, and we
investigated the prevalence of urine abnormalities and inci-
dence and the causes of their diseases. Therefore, we studied
effectiveness of the school-screening program.
Results. The prevalence of urinary abnormalities was 0.52%
among elementary school children and 0.75% among junior
high school children. The incidence was 0.24% among elemen-
tary school children. The school-screening program is effective
in early detection of glomerulonephritis, so the number of new
end-stage renal disease (ESRD) patients starting treatment has
been changing.
Discussion. The school-screening program is effective for
early detection of glomerulonephritis. In case of generations
who underwent the school-screening program, the age that one
develops ESRD has been rising year by year, and the number
of new ESRD patients starting treatment before 20 years old is
lower in Japan than in America.
Conclusion. The school-screening program in Japan repre-
sents a highly effective mass screening technique.
In Japan, the school-screening program is used to
screen for proteinuria and hematuria in school-aged chil-
dren. Since a 1973 revision in the School Health Law,
urine screening has been performed every year since 1974
in elementary and junior high schools for the early detec-
tion of nephropathies and uropathies.
The present study investigated whether this screening
program is effective in reducing the number of patients
requiring renal replacement therapy (RRT).
METHODS
Prevalence and incidence of urinary abnormalities in
elementary and junior high school children in Japan
Since 1974, we have been conducting screening by us-
ing reagent strips produced by the same manufacturer
(Bayer Corporation, Elkhart, IN, USA), and analyzed
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using the same standards [1]. In the first screening, ele-
mentary and junior high school children are instructed to
completely empty the bladder at night, and early morning
urine is sampled to screen for urinary protein and occult
blood. For both proteinuria and hematuria, positive reac-
tions are defined as ± or above. A sulphosalicylic acid test
is used to confirm proteinuria, while microscopy is per-
formed to confirm occult hematuria. Children who gave
positive results in the first test were examined again 10 to
20 days later using the same methods. If both of the sets of
tests are positive, children will undergo a second screen-
ing. In this second screening, besides urinalysis, each child
is interviewed and examined by a physician, a blood sam-
ple is taken, and blood pressure is measured. Based on
the results of these tests, further tests are ordered as nec-
essary.
To ascertain the incidence of urinary abnormalities,
31,552 elementary school children who began attending
elementary school in 1987 were followed for six years.
Urine screening was performed over the six-year period
on more than 96% of the elementary school children.
The first urinalysis was conducted soon after entering el-
ementary school, and incidence of urinary abnormality
was monitored annually for the next five years.
Final diagnosis for children with positive test results
Precise tests were conducted on a total of 425 children
who visited Nippon Medical School hospital. They were
diagnosed with urinary abnormality based on results of
the second screening, which has been conducted for the
last 29 years using the same reagent strips and standards.
The next examination step for children found to have
positive finding on the second screening should be one
that enables a definitive diagnosis to be made. That is to
say, measurements of serum complements, serum IgA,
urine b2-microglobulin, urine Ca/creatinine, and renal
sonography are added to routine test. Kidney biopsy was
conducted for children satisfying the following criteria:
(1) proteinuria ≥100 mg/dL (early morning urine); (2)
abnormal clinical or serum findings (e.g., edema, hyper-
tension, renal dysfunction, hypoproteinemia, hypocom-
plementemia); (3) senior elementary school children
(over 9 years old) and junior high school students
with proteinuria and hematuria; and (4) macroscopic
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Fig. 1. Prevalence of the first screening (elementary school child).
hematuria without urologic disease, left renal vein en-
trapment syndrome, or hypercalciuria.
RESULTS
Prevalence and incidence of urinary abnormalities in
elementary and junior high school children in Japan
Since 1974, we have conducted urine screenings on
more than 200,000 elementary school children (6 to
11 years old) and 100,000 junior high school children
(12 to 14 years old) each year. Figures 1 and 2 show
results for the first screening in elementary and junior
high school children from 1974 to 2002. In 2002, urinal-
ysis was conducted for 246,368 elementary school chil-
dren and 115,736 junior high school children. In the
first screening, positive rates of proteinuria, proteinuria
with hematuria, and hematuria were 0.11%, 0.05%, and
0.83%, respectively, among elementary school children,
and 0.6%, 0.10%, and 1.10%, respectively, among ju-
nior high school children. In the second screening, posi-
tive rates of proteinuria, proteinuria with hematuria, and
hematuria were 0.06%, 0.01%, and 0.45%, respectively,
among elementary school children, and 0.32%, 0.03%,
and 0.40%, respectively, among junior high school chil-
dren.
Out of the 31,552 elementary school children who
began to attend school in 1987, 384 children (1.22%),
comprising 131 boys (0.8%) and 253 girls (1.66%), were
found to have urine abnormalities over the six-year pe-
riod. Breakdown of urinary abnormalities was as follows:
proteinuria (N = 54; 14.1%), proteinuria with hematuria
(N = 30; 7.8%), and hematuria (N = 300; 78.1%). Based
on these findings, annual incidence of urinary abnormal-
ity in elementary school children from 6 to 10 years old is
0.03% for proteinuria, 0.02% for proteinuria with hema-
turia, and 0.19% for hematuria [2].
Final diagnosis for children with positive test results
Breakdown of pathologies for the 425 children was:
proteinuria, N = 96; proteinuria with hematuria, N = 49;
proteinuria with leukocyturia, N = 5; and hematuria, N =
275. Table 1 shows final diagnoses. Final diagnosis was
made in 9.4% of children with proteinuria, 67.3% of chil-
dren with proteinuria with hematuria, 80% of children
with proteinuria with leukocyturia, and 4.7% of children
with hematuria. We diagnosed children who were not
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Fig. 2. Prevalence of the first screening (junior high school child).
Table 1. Final diagnosis of the positive cases
Isolated Proteinuria Proteinuria with Isolated
proteinuria with hematuria leukocyturia hematuria
N 96 49 5 275
No abnormal urinea 1 40
Postural P 44 1
Asymptomatic P 42
Asymptomatic H 7 220
Asymptomatic P and H 9 2
Urinary tract infection 1 1 4
Urinary tract malformation 4 1 5
Glomerulonephritis 1 30 6
Others 3 1 2
Abbreviations are: P, proteinuria; H, hematuria; P and H, proteinuria and hematuria.
aThe patients had urinary abnormalities in the second screening.
given the name of diseases as isolated proteinuria, asymp-
tomatic proteinuria with hematuria, or isolated hema-
turia [3].
Histologic examination of the kidney was conducted
for 54 children (Table 2)[3]. In the second screening, ex-
cluding those with minor glomerular abnormalities, pos-
itive rates of glomerulonephritis was 1.0% for children
with proteinuria, 61.2% for children with proteinuria with
hematuria, and 2.2% for children with hematuria. Based
on these findings and the above incidences of urinary
abnormalities, incidence of glomerulonephritis in school
children from 6 to 10 years old was estimated at 0.016%
(5.1/31,552 children) per year.
DISCUSSION
In these results, annual incidence of urinary abnormal-
ity in elementary school children from 6 to 10 years old is
0.03% for proteinuria, 0.02% for proteinuria with hema-
turia, and 0.19% for hematuria [2]. Further, incidence of
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Table 2. Details of glomerulonephritis
Isolated Proteinuria Isolated
proteinuria with hematuria hematuria
N 7 34 13
MGA 6 4 7
IgA nephropathy 21 6
Non-IgA mes. PGN 1
MPGN 4
MN 1 3
FSGS 1
Abbreviations are: MGA, minor glomerular abnormalities; mes. PGN,
mesangial proliferative glomerulonephritis; MPGN, membranoproliferative
glomerulonephritis; MN, membranous nephropathy; FSGS, focal segmental
glomerular sclerosis.
glomerulonephritis in school children from 6 to 10 years
old was estimated at 0.016% (5.1/31,552 children) per
year. These results suggest that the school-screening pro-
gram is, thus, effective for early detection of glomeru-
lonephritis.
Comparing Japan, with its mandatory school screening
program, and America, which does not have any such
program, 29 children <20 years old developed end-stage
renal disease (ESRD) from primary glomerulonephritis
in 1999 in Japan [4], while an average of 311 children
<20 years old developed ESRD each year between 1996
and 1999 in America [5]. Adjusted for population, the
value of ESRD in America is 111, about 4-fold higher
than in Japan.
Regarding therapeutic responsiveness of early-stage
glomerulonephritis, studies have been conducted on
membranoproliferative glomerulonephritis (MPGN)
and IgA nephropathy, which are often asymptomatic.
Iidaka et al studied therapeutic outcomes for 41
Japanese children with MPGN, including 29 children
diagnosed with MPGN based on the results of school
screenings, and reported that only one child developed
ESRD [6]. According to Iidaka et al, outcomes for MPGN
patients were superior compared to other studies due to
earlier detection and treatment. We have followed 20 pa-
tients who were diagnosed with type I MPGN based on
the results of school screenings for more than 10 years,
and none of these children have yet developed ESRD.
Yoshikawa et al studied children with IgA nephropathy;
among them, about 70% were diagnosed based on re-
sults of school screenings. And they concluded that in
case of the patients with early detection and treatment,
the disease would be delayed [7]. These findings suggest
that early detection led to early treatment with lower in-
cidence of ESRD complicated.
In Japan, a total of 229,538 patients were on dialysis in
2002, and 33,710 new ESRD patients were starting treat-
ment. The number of new dialysis patients has increased
by about 1000 each year [8]. According to the Japanese
Society for Dialysis Therapy, the number of new ESRD
patients starting treatment <20 years old was 174 in 1984
compared to 108 in 2002. Moreover, pediatric peritoneal
dialysis has been performed more often in recent years,
and the number of new ESRD patients starting treatment
before 12 months old was eight in 1984 compared to 22
in 2002. We have a conclusion from this result that the
number of new ESRD patients starting treatment <20
years old has not been increasing in 2002 in comparison
to 1984.
Yamagata et al investigated the age distribution of pa-
tients who began maintenance RRT from 1983 to 1999
in Japan, and found that the average age of patients with
ESRD has increased in recent years [9]. Their data in-
dicate that the number of new ESRD patients starting
treatment has decreased for patients <30 years old since
around 1990, for patients <35 years old since around
1995, and for patients <40 years old since around 1999.
Furthermore, according to Yamagata et al, among pa-
tients with glomerulonephritis, the incidence rate for
Japanese was greater than those for other races in all
age groups in 1983; however, in 1999, the incidence rate
for Japanese patients with glomerulonephritis was lowest
in the younger than 25-year-old group, and lower than
in U.S. blacks in the younger than 55-year-old group.
These findings suggest that Japanese children who un-
dergo annual urine screening at school tend to develop
ESRD at a later stage of life than is comparable American
populations.
In Japan in 1999, age distribution for new ESRD
patients starting treatment <20 years old was as
follows: 3 per million among 0- to 4-year-olds; 2 per
million among 5- to 9-year-olds; 5 per million among 10-
to 14-year-olds; 6 among 15- to 19-year-olds. In total pop-
ulation <20 years old, the number of new ESRD patients
starting treatment was 4 patients per million [4]. In Amer-
ica in 1999, this figure was 10 per million among 0- to 4-
year-olds; 8 per million among 5- to 9-year-olds; 16 per
million among 10- to 14-year-olds; 30 per million among
15- to 19-year-olds. In total population <20 years old, the
number of new ESRD patients starting treatment was 16
patients per million [5]. Since the school screening pro-
gram is conducted on school-aged children ≥6 years old,
no effect is seen on children <6 years old, but differences
between the two countries in the number of new ESRD
patients starting treatment at higher age groups could be
partially attributable to the benefits of the screening pro-
gram.
CONCLUSION
The school-screening program in Japan represents an
effective mass screening technique; compared to children
who did not participate in the mass-screening program,
nephropathies were more responsive to therapy, ESRD
took longer to progress, and incidence of ESRD was
lower.
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